Title : Use of heterologously expressed human cytochrome P450 1A2 to predict tacrine-fluvoxamine drug interaction in man - Becquemont_1998_Pharmacogenet_8_101 |
Author(s) : Becquemont L , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P , Beaune P |
Ref : Pharmacogenetics , 8 :101 , 1998 |
Abstract : |
PubMedSearch : Becquemont_1998_Pharmacogenet_8_101 |
PubMedID: 10022747 |
Title : The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms - Haaz_1997_Naunyn.Schmiedebergs.Arch.Pharmacol_356_257 |
Author(s) : Haaz MC , Rivory LP , Riche C , Robert J |
Ref : Naunyn Schmiedebergs Arch Pharmacol , 356 :257 , 1997 |
Abstract : |
PubMedSearch : Haaz_1997_Naunyn.Schmiedebergs.Arch.Pharmacol_356_257 |
PubMedID: 9272733 |
Title : Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans - Becquemont_1997_Clin.Pharmacol.Ther_61_619 |
Author(s) : Becquemont L , Ragueneau I , Le Bot MA , Riche C , Funck-Brentano C , Jaillon P |
Ref : Clinical Pharmacology & Therapeutics , 61 :619 , 1997 |
Abstract : |
PubMedSearch : Becquemont_1997_Clin.Pharmacol.Ther_61_619 |
PubMedID: 9209244 |
Title : Influence of fluvoxamine on tacrine metabolism in vitro: potential implication for the hepatotoxicity in vivo - |
Author(s) : Becquemont L , Le Bot MA , Riche C , Beaune P |
Ref : Fundamental & Clinical Toxicology , 10 :156 , 1996 |
PubMedID: 8737959 |
Title : Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction - Berson_1996_Gastroenterology_110_1878 |
Author(s) : Berson A , Renault S , Letteron P , Robin MA , Fromenty B , Fau D , Le Bot MA , Riche C , Durand-Schneider AM , Feldmann G , Pessayre D |
Ref : Gastroenterology , 110 :1878 , 1996 |
Abstract : |
PubMedSearch : Berson_1996_Gastroenterology_110_1878 |
PubMedID: 8964414 |